NCT03547596

Brief Summary

To treat lower urinary tract symptoms (LUTS) and erectile dysfunction (ED), we mainly have symptomatic drug treatments. Some patients are resistant to the treatments that we have or are forced to stop treatments because of side effects. It would be interesting to focus on comorbidities and to evaluate whether it is possible to improve the urological symptoms by taking care the comorbidities, which would consist in an etiological treatment of the urological symptoms. The aim of the study is to evaluate the evolution of low urinary tract disorders (LUTS) and erectile dysfunction (ED) in patients with obstructive sleep apnea syndrome (OSAS) following by continuous positive airway pressure equipment (CPAP) at night. Participation in the study will be offered to all patients, men and women, consulting or hospitalized in the sleep unit of the department of pneumology CHU of Reims for a nocturnal ventilatory polygraphy or a polysomnography diagnostic of OSAS. Men will complete three questionnaires about LUTS and DE, women one questionnaire about LUTS. The questionnaires will be completed twice, the first time when consulting at the sleep unit for nocturnal ventilatory polygraphy or a polysomnography diagnostic of OSAS ; the second time during the pneumology consultation three months later. We will compare the results between the questionnaires to assess whether OSAS equipment with CPAP has improved urologic symptoms. If the management of OSAS allows an improvement of lower urinary tract disorders and / or an improvement of erectile dysfunction, these results would be interesting for the management of patients resistant to symptomatic drug treatments or to stop them because of iatrogenic side effects. Etiological rather than symptomatic management would also have long-term benefits, both in improving the overall quality of life of the patient and in the medical and economic field. It might be interesting to identify in urology consultation among patients consulting for LUTS or ED, patients at risk of presenting OSAS and referring them to a pulmonologist to manage OSAS if it exists, from the beginning of the urological care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2018

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

May 24, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 6, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2020

Completed
Last Updated

December 4, 2018

Status Verified

May 1, 2018

Enrollment Period

10 months

First QC Date

May 24, 2018

Last Update Submit

December 3, 2018

Conditions

Keywords

Lower urinary tract symptomsErectile dysfunctionObstructive Sleep Apneas Syndrom

Outcome Measures

Primary Outcomes (2)

  • lower urinary tract symptoms

    Evaluation of the lower urinary tract symptoms using "UrinarySymptom Profil"

    Day 0

  • erectile dysfunction

    Evaluation of the lower urinary tract symptoms using "International Index of Erectile Function"

    Day 0

Interventions

Questionnaires to evaluate lower urinary tract symptoms and erectile dysfunction.

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over 18 years, men and women, managed in the sleep unit of Reims University Hospital for the realization of a nocturnal ventilatory polygraphy or polysomnography in search of an OSAS during the inclusion phase and accepting to participate in the study.

You may qualify if:

  • managed at the sleep unit at Reims University Hospital for the diagnosis of sleep apnea syndrome by nocturnal airway polygraphy or polysomnography
  • major
  • accepting participation in the study (signed non-opposition form)

You may not qualify if:

  • refusing to be included in the study
  • minors
  • not speaking French or not able to read (inability to complete the questionnaires specific to the study).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

RECRUITING

MeSH Terms

Conditions

Lower Urinary Tract SymptomsErectile Dysfunction

Condition Hierarchy (Ancestors)

Urological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2018

First Posted

June 6, 2018

Study Start

April 29, 2018

Primary Completion

February 28, 2019

Study Completion

February 28, 2020

Last Updated

December 4, 2018

Record last verified: 2018-05

Locations